Prescription Required
Formulation: Tablet
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Plavix with Aspirin is a combination of two antiplatelet medications used to reduce the risk of harmful blood clots in patients with certain cardiovascular conditions.
Plavix contains clopidogrel, while aspirin contains acetylsalicylic acid (ASA). Both medications help prevent platelets, which are small blood cells involved in clot formation, from sticking together and forming dangerous clots.
When clopidogrel and aspirin are prescribed together, the treatment is known as dual antiplatelet therapy (DAPT).
This treatment is commonly recommended for patients with acute coronary syndrome (ACS), including certain types of heart attacks and unstable angina. It may also be prescribed after coronary procedures, such as angioplasty and stent placement.
Plavix and aspirin work together to reduce the risk of heart attacks, certain strokes, and other complications caused by blood clots. However, the combination also increases bleeding risk and should only be used under medical supervision.Â
Plavix with Aspirin may be prescribed to help prevent cardiovascular events in patients who have certain heart or blood vessel conditions.
Cardiovascular disease can cause fatty deposits, called plaques, to build up inside the arteries. This condition is known as atherosclerosis.
Over time, these plaques may narrow the arteries and reduce blood flow to important organs, including the heart and brain.
If a plaque ruptures, platelets can gather at the damaged area and form a blood clot.
A large blood clot may partially or completely block an artery, potentially causing a heart attack or ischemic stroke.
Clopidogrel and aspirin work through different mechanisms to reduce platelet activity and make harmful clot formation less likely.
Clopidogrel blocks a platelet receptor called P2Y12, while aspirin inhibits the production of thromboxane A2, a substance that promotes platelet aggregation.
Together, these medications provide greater inhibition of platelet activity than either medication alone.
However, dual antiplatelet therapy is not appropriate for every patient with cardiovascular disease.
The need for combination treatment depends on the patient’s medical history, recent cardiovascular events, and risk of bleeding.
Plavix with Aspirin helps reduce the risk of harmful blood clots in selected patients with cardiovascular disease. Your healthcare provider will determine whether dual antiplatelet therapy is appropriate for you.
Plavix with Aspirin is commonly used in patients with acute coronary syndrome, a group of conditions caused by a sudden reduction in blood flow to the heart.
Acute coronary syndrome includes unstable angina and certain types of heart attacks.
Unstable angina occurs when the heart muscle does not receive enough oxygen-rich blood, causing chest pain or discomfort that may develop suddenly or worsen over time.
A heart attack, also called a myocardial infarction, occurs when reduced blood flow causes injury to the heart muscle.
In many cases, these conditions develop when a blood clot forms inside a coronary artery.
Dual antiplatelet therapy helps prevent platelets from accumulating and forming additional clots.
This can reduce the risk of another heart attack, certain strokes, and other serious cardiovascular complications.
For patients with acute coronary syndrome who are not at high risk of bleeding, current guidelines generally recommend aspirin combined with a P2Y12 inhibitor for approximately 12 months or longer when appropriate.
Clopidogrel is one possible P2Y12 inhibitor, although other medications, such as ticagrelor or prasugrel, may be preferred in certain patients.
Plavix with Aspirin may help reduce the risk of recurrent heart attacks and other cardiovascular complications in patients with acute coronary syndrome. The choice of medication and duration of treatment depend on individual risk factors.Â
Plavix with Aspirin may be prescribed after a procedure called percutaneous coronary intervention (PCI).
PCI is a minimally invasive procedure used to open narrowed or blocked coronary arteries and improve blood flow to the heart.
During the procedure, a healthcare professional may insert a small balloon into the affected artery to widen it.
A coronary stent, which is a small mesh-like tube, may also be placed inside the artery to help keep it open.
Although stents improve blood flow, platelets may attach to their surfaces and form blood clots.
This complication is called stent thrombosis.
Stent thrombosis can suddenly block blood flow through the treated artery and may cause a serious heart attack.
Dual antiplatelet therapy helps reduce this risk by inhibiting platelet aggregation.
The length of treatment depends on several factors, including the type of stent, whether the patient experienced a heart attack, and the risk of bleeding.
Some patients require dual antiplatelet therapy for several months, while others may need a longer treatment period.
Plavix with Aspirin may help prevent dangerous blood clots from forming inside coronary stents. Never stop either medication without consulting your cardiologist, as premature discontinuation may increase the risk of stent thrombosis and heart attack.
Plavix with Aspirin may also be used in selected patients following coronary artery bypass graft surgery.
Coronary artery bypass grafting (CABG) is a surgical procedure that creates a new pathway for blood to flow around severely narrowed or blocked coronary arteries.
The procedure usually involves using a blood vessel from another part of the body to bypass the affected artery.
After surgery, antiplatelet medications help reduce the likelihood of blood clots developing in the grafts or coronary arteries.
Aspirin is commonly prescribed after CABG to support graft function and reduce cardiovascular complications.
In certain patients, particularly those who underwent surgery following acute coronary syndrome, clopidogrel or another P2Y12 inhibitor may also be prescribed.
However, dual antiplatelet therapy is not routinely required for every patient who undergoes bypass surgery.
Because these medications increase bleeding risk, the healthcare team must carefully consider when to begin or resume treatment after surgery.
Plavix with Aspirin may be used after CABG surgery in selected patients, particularly those with acute coronary syndrome. The treatment schedule must be determined by the cardiologist and surgical team.Â
Clopidogrel and aspirin may be used together for a limited period in selected patients who have experienced a minor ischemic stroke or a high-risk transient ischemic attack (TIA).
An ischemic stroke occurs when a blood clot blocks an artery supplying blood to the brain.
A transient ischemic attack, sometimes called a mini-stroke, causes temporary stroke-like symptoms due to a brief interruption of blood flow to the brain.
After these events, patients may have an increased risk of experiencing another stroke.
Short-term dual antiplatelet therapy may help reduce the risk of recurrent ischemic stroke in appropriately selected patients.
However, combination therapy is not generally recommended indefinitely for routine stroke prevention because prolonged treatment increases bleeding risk.
Plavix with Aspirin is also not used to treat hemorrhagic stroke, which occurs when a blood vessel ruptures and causes bleeding in or around the brain.
In patients with certain conditions, such as atrial fibrillation, anticoagulant medications may be more appropriate than antiplatelet therapy for stroke prevention.
Plavix with Aspirin may help prevent recurrent ischemic strokes in selected patients, but the treatment duration is usually limited. Not all stroke patients should receive this combination.
Plavix and aspirin belong to a class of medications called antiplatelet agents.
Platelets are small blood cells that help stop bleeding when a blood vessel is injured.
Normally, platelets stick together to form a temporary plug at the site of an injury.
This process is known as platelet aggregation.
Although platelet aggregation is important for normal blood clotting, excessive platelet activity can cause dangerous clots to form inside arteries.
Plavix and aspirin inhibit platelet aggregation through different pathways.
How Clopidogrel Works
Clopidogrel blocks the P2Y12 receptor on platelets.
This receptor normally responds to adenosine diphosphate (ADP), a substance that helps activate platelets.
By blocking this receptor, clopidogrel reduces platelet activation and prevents platelets from sticking together as easily.
Clopidogrel must first be converted into its active form by liver enzymes, including CYP2C19.
Certain genetic differences and medications may reduce this activation and make clopidogrel less effective.
How Aspirin Works
Aspirin blocks an enzyme called cyclooxygenase-1 (COX-1).
This reduces the production of thromboxane A2, a substance that helps platelets become activated and aggregate.
By reducing thromboxane A2 production, aspirin decreases platelet activity and helps prevent blood clots.
How the Combination Works
When clopidogrel and aspirin are taken together, they inhibit two separate pathways involved in platelet activation.
This produces a stronger antiplatelet effect than either medication alone.
However, stronger platelet inhibition also increases the risk of bleeding.
Plavix blocks ADP-mediated platelet activation, while aspirin reduces thromboxane A2 production. Together, they help prevent harmful blood clots and reduce the risk of certain cardiovascular events.
Plavix and aspirin begin reducing platelet activity after they are absorbed into the body.
Aspirin generally starts inhibiting platelet function relatively quickly after administration.
Clopidogrel requires activation by liver enzymes before it can effectively block platelet activity.
For patients who need rapid antiplatelet effects, healthcare providers may prescribe an initial higher dose of clopidogrel, called a loading dose.
This helps the medication produce its antiplatelet effects more quickly.
Patients who take clopidogrel without a loading dose generally develop its full antiplatelet effect more gradually over several days.
However, patients usually do not feel a noticeable physical change when these medications begin working.
Plavix with Aspirin is intended to prevent blood clots rather than relieve symptoms such as chest pain immediately.
The medications must be taken consistently according to the prescribed schedule.
Plavix and aspirin begin affecting platelet activity after administration, but their benefits are preventive and may not produce noticeable symptoms. Continue taking both medications exactly as prescribed.
Plavix contains clopidogrel, while aspirin contains acetylsalicylic acid.
They are often prescribed as separate tablets taken together as dual antiplatelet therapy. Whether a combined product is available depends on the country and manufacturer.
The appropriate dosage and duration depend on the cardiovascular condition being treated.
Common side effects may include easy bruising, nosebleeds, and stomach discomfort.
More serious complications include gastrointestinal bleeding, internal bleeding, and, rarely, bleeding in the brain.
Tell your healthcare provider if you have a history of bleeding disorders, stomach ulcers, liver disease, or previous hemorrhagic stroke.
Certain medications, including anticoagulants and nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen, may increase bleeding risk when combined with Plavix and aspirin.
Clopidogrel may also interact with medications such as omeprazole and esomeprazole, which can reduce its antiplatelet effectiveness.
Seek emergency medical attention if you experience vomiting blood, black or bloody stools, uncontrolled bleeding, sudden severe headache, or symptoms of a stroke. Do not stop Plavix or aspirin without consulting your healthcare provider.
Plavix with Aspirin is an antiplatelet treatment used to help prevent harmful blood clots in patients with certain cardiovascular conditions, including acute coronary syndrome (ACS), heart attacks, and patients who have undergone coronary stent placement.
Plavix contains clopidogrel, while aspirin contains acetylsalicylic acid (ASA). These medications work together to prevent platelets from sticking together and forming blood clots that could block blood flow to the heart or brain.
Using clopidogrel and aspirin together is called dual antiplatelet therapy (DAPT).
The medications may be prescribed as separate tablets or as a fixed-dose combination tablet, depending on product availability.
Although this combination can significantly reduce the risk of certain cardiovascular events, it also increases the risk of bleeding. Careful dosing and medical supervision are therefore essential.
Take Plavix with Aspirin exactly as prescribed. Do not change your dosage or stop either medication without consulting your healthcare provider, particularly if you have recently undergone coronary stent placement.
Clopidogrel and aspirin may be prescribed as individual tablets or in a fixed-dose combination.
Certain combination products contain both medications in a single tablet, making it easier for patients to follow their prescribed treatment schedule.
Examples of established fixed-dose combination strengths include:
The available strengths depend on the specific product and country. A 75 mg/150 mg strength should not be assumed to be available without checking the product’s approved labeling.
For patients taking the medications separately, clopidogrel is commonly prescribed as a 75 mg tablet, while the aspirin dose depends on the treatment plan.
Your healthcare provider will determine whether separate tablets or a fixed-dose combination is appropriate.
Always check the strength printed on your prescription label. Do not substitute one combination product for another without consulting your healthcare provider or pharmacist.Â
The recommended dosage depends on the cardiovascular condition being treated, the patient’s age, medical history, and risk of bleeding.
For many adults receiving dual antiplatelet therapy, the usual maintenance dose of clopidogrel is 75 mg once daily.
Aspirin is commonly prescribed at a low maintenance dose of 75–100 mg once daily, with 81 mg being a frequently used strength.
For certain patients experiencing acute coronary syndrome, treatment may begin with a higher initial dose of clopidogrel, known as a loading dose.
The loading dose helps produce an antiplatelet effect more quickly.
Depending on the clinical situation, the initial clopidogrel dose may be 300 mg or 600 mg, followed by a maintenance dose of 75 mg daily.
Aspirin may also be administered at an initial loading dose of 162–325 mg before continuing at a lower daily dose.
However, not every patient requires a loading dose, and the appropriate regimen depends on the type of cardiovascular event and treatment being provided.
Older adults and patients with a high risk of bleeding may require a different approach.
The usual maintenance regimen often includes clopidogrel 75 mg daily with low-dose aspirin, but loading doses and individual treatment plans must be determined by a healthcare provider.Â
The recommended duration of dual antiplatelet therapy depends on the patient’s cardiovascular condition, type of treatment received, and risk of bleeding.
For patients with acute coronary syndrome who are not at high risk of bleeding, dual antiplatelet therapy is generally recommended for at least 12 months.
However, the treatment duration may be shortened or modified for patients who have an increased risk of bleeding.
For patients who undergo coronary stent placement, the duration of treatment depends on whether the stent was placed for acute coronary syndrome or stable coronary artery disease.
Some patients may require several months of dual antiplatelet therapy, while others may need treatment for 12 months or longer.
Patients who have undergone coronary stent placement should be particularly careful about stopping treatment prematurely.
Discontinuing antiplatelet medications too early may increase the risk of stent thrombosis, a potentially life-threatening complication in which a blood clot forms inside a coronary stent.
Your cardiologist will determine how long both medications are necessary and whether one medication should be continued after dual therapy ends.
Dual antiplatelet therapy is commonly continued for approximately 12 months after acute coronary syndrome, but treatment duration must be individualized. Never stop Plavix or aspirin without consulting your healthcare provider.Â
Because Plavix and aspirin both reduce platelet activity, taking them together increases the risk of bleeding.
Platelets are blood cells that help form clots to stop bleeding after an injury.
When platelet activity is reduced, bleeding may take longer to stop, even after a minor cut or injury.
Some patients may experience easy bruising, occasional nosebleeds, or minor bleeding from the gums.
However, unusual or persistent bleeding may indicate a more serious complication.
Patients should take precautions to reduce the risk of injury, particularly during activities that may involve falls, cuts, or physical contact.
Using a soft-bristled toothbrush and an electric razor may help reduce minor bleeding.
Tell your healthcare provider if you notice frequent bruising, prolonged bleeding from small cuts, persistent nosebleeds, or blood in your urine.
Seek immediate medical attention if you experience severe or uncontrolled bleeding, vomiting blood, black or tarry stools, or symptoms of bleeding in the brain, such as a sudden severe headache accompanied by neurological changes.
Report unusual bruising or bleeding promptly. Seek emergency medical assistance for severe bleeding, vomiting blood, black stools, or sudden neurological symptoms.
Patients taking Plavix with Aspirin should attend regular medical appointments to assess treatment effectiveness and identify potential complications.
Your healthcare provider will review your cardiovascular condition, bleeding risk, other medications, and overall response to treatment.
Depending on your medical history, blood tests may be recommended to monitor blood counts or investigate suspected bleeding.
Your healthcare provider may also review medications that increase bleeding risk, including anticoagulants, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antidepressants.
Some medications, including omeprazole and esomeprazole, may reduce the effectiveness of clopidogrel by interfering with its activation in the liver.
Inform your healthcare provider and pharmacist about all prescription medications, over-the-counter products, and supplements you use.
Regular medical follow-up is important while taking Plavix with Aspirin. Tell your healthcare provider about unusual bleeding, new medications, or any planned medical or dental procedures.
Plavix with Aspirin helps reduce the risk of cardiovascular events by preventing platelets from forming harmful blood clots.
The medications may be prescribed separately or as a fixed-dose combination tablet.
Dosage and treatment duration depend on the patient’s cardiovascular condition, previous procedures, and bleeding risk.
Although the combination is commonly used following acute coronary syndrome and coronary stent placement, it is not appropriate for every patient.
The most important safety concern is an increased risk of bleeding, which may become serious in some individuals.
Take both medications consistently, follow your prescribed dosage, attend medical follow-up appointments, and never stop treatment without consulting your healthcare provider.
Plavix with Aspirin (Clopidogrel/Aspirin) is available in the following forms and strength:
Plavix with Aspirin is an antiplatelet treatment used to reduce the risk of harmful blood clots in patients with certain cardiovascular conditions, including acute coronary syndrome (ACS), heart attacks, and coronary stent placement.
Plavix contains clopidogrel, while aspirin contains acetylsalicylic acid (ASA). Both medications help prevent platelets from sticking together and forming blood clots that could block blood flow to the heart or brain.
When taken together, these medications provide a treatment known as dual antiplatelet therapy (DAPT).
Although this combination can reduce the risk of certain heart attacks and strokes, it also increases the risk of bleeding. Some patients may require additional precautions because of existing medical conditions, medication interactions, or differences in how their bodies process clopidogrel.
Plavix with Aspirin should only be used under medical supervision. Do not stop either medication or change your dosage without consulting your healthcare provider, especially if you have recently undergone coronary stent placement.
One of the most important risks associated with Plavix and aspirin is an increased likelihood of bleeding.
Platelets are small blood cells that help stop bleeding by forming clots when a blood vessel is injured.
Clopidogrel and aspirin interfere with platelet activity through different mechanisms. When used together, they provide stronger protection against harmful blood clots, but they also make it more difficult for the body to stop bleeding.
Patients may experience easy bruising, frequent nosebleeds, bleeding gums, or prolonged bleeding from minor cuts.
More serious complications may include bleeding in the stomach, intestines, or brain.
The risk may be higher in patients who have a history of bleeding disorders, stomach ulcers, or previous gastrointestinal bleeding.
Taking other medications that affect blood clotting can further increase this risk.
These include anticoagulants such as warfarin, apixaban, and rivaroxaban, as well as nonsteroidal anti-inflammatory drugs (NSAIDs).
Patients should take precautions to reduce injuries and report unusual bleeding to their healthcare provider.
Warning signs of serious bleeding include vomiting blood, black or tarry stools, blood in the urine, and bleeding that does not stop.
Contact your healthcare provider if you experience unusual bruising or repeated minor bleeding. Seek emergency medical attention for severe or uncontrolled bleeding, vomiting blood, black stools, or sudden neurological symptoms.
Plavix with Aspirin is prescribed to reduce the risk of serious cardiovascular events, but it does not completely eliminate the possibility of a heart attack or stroke.
Some patients may continue to develop blood clots despite taking antiplatelet medications.
The effectiveness of treatment depends on several factors, including the patient’s cardiovascular condition, medication adherence, and how well the body responds to clopidogrel.
Certain patients may have a reduced response to clopidogrel because their bodies cannot efficiently convert it into its active form.
This can increase the risk of future cardiovascular events, particularly after coronary stent placement.
It is also important to recognize that dual antiplatelet therapy may not be appropriate for every patient.
In people who do not have a clear medical reason to receive combination therapy, the increased risk of serious bleeding may outweigh its potential benefits.
However, it is not accurate to say that Plavix with Aspirin generally increases the risk of heart attacks or death. In appropriately selected patients, the combination is specifically used to reduce the risk of serious cardiovascular complications.
Stopping treatment prematurely can also increase the risk of heart attack or stent thrombosis, particularly following coronary stent placement.
Your healthcare provider will determine whether dual antiplatelet therapy is appropriate based on your medical history, cardiovascular risk, and bleeding risk.
Plavix with Aspirin is intended to prevent cardiovascular events, but its benefits and risks vary between patients. Never stop treatment suddenly without consulting your cardiologist.
Plavix with Aspirin may interact with several prescription medications, over-the-counter drugs, and herbal supplements.
Some interactions increase the risk of bleeding, while others may reduce the effectiveness of clopidogrel.
Before starting treatment, tell your healthcare provider about all medications and supplements you take.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Medications such as ibuprofen and naproxen may increase the risk of stomach irritation, gastrointestinal ulcers, and bleeding when combined with Plavix and aspirin.
Avoid taking additional NSAIDs unless your healthcare provider specifically recommends them.
Anticoagulants and Other Blood Thinners
Anticoagulants such as warfarin, apixaban, and rivaroxaban can significantly increase bleeding risk when used alongside dual antiplatelet therapy.
Some patients require these combinations for specific cardiovascular conditions, but they need careful medical supervision.
Proton Pump Inhibitors (PPIs)
Proton pump inhibitors are medications used to reduce stomach acid and treat conditions such as acid reflux and stomach ulcers.
Certain PPIs, particularly omeprazole and esomeprazole, can reduce the activation of clopidogrel in the liver.
This may decrease its ability to prevent platelet aggregation.
However, not all PPIs have the same effect. Pantoprazole, for example, has less effect on clopidogrel activation and may be considered when stomach protection is necessary.
Patients at increased risk of gastrointestinal bleeding may benefit from an appropriately selected PPI while receiving dual antiplatelet therapy.
Certain Antidepressants
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) may increase bleeding risk when combined with Plavix and aspirin.
Your healthcare provider may recommend additional precautions if you require these medications.
Tell your healthcare provider about all medications and supplements you take. Do not stop prescribed treatments independently, and avoid using additional pain relievers or acid-reducing medications without checking for interactions.Â
Some patients may not respond adequately to Plavix because of genetic differences affecting how their bodies process clopidogrel.
Clopidogrel is a prodrug, meaning it must first be converted into its active form before it can prevent platelet aggregation.
This conversion occurs primarily in the liver and involves an enzyme called CYP2C19.
Some people inherit genetic variations that reduce the activity of this enzyme.
These individuals are known as CYP2C19 poor metabolizers.
When CYP2C19 activity is reduced, the body produces less active clopidogrel.
As a result, clopidogrel may not prevent platelet aggregation as effectively as expected.
This may increase the risk of blood clots, heart attacks, or stent thrombosis in patients who depend on clopidogrel for cardiovascular protection.
Genetic testing is available to identify certain CYP2C19 variations.
Your healthcare provider may consider testing based on your medical history, cardiovascular condition, and treatment requirements.
If clopidogrel is expected to be less effective, another antiplatelet medication may be recommended.
Some patients process clopidogrel less effectively because of CYP2C19 genetic variations. Your healthcare provider may recommend genetic testing or an alternative medication when appropriate.Â
Patients taking Plavix with Aspirin should attend regular medical appointments to evaluate the safety and effectiveness of treatment.
Your healthcare provider will review your cardiovascular history, current medications, bleeding risk, and response to antiplatelet therapy.
Certain patients may require blood tests to monitor for anemia or other signs of blood loss.
Your healthcare provider may also assess whether additional precautions are necessary if you have a history of stomach ulcers, kidney disease, liver disease, or bleeding disorders.
Tell your healthcare provider if you experience persistent nosebleeds, unusual bruising, bleeding gums, or blood in your urine or stool.
It is also important to inform your healthcare provider before undergoing surgery, dental procedures, or other treatments that may increase bleeding risk.
Some procedures may require temporary changes to antiplatelet therapy.
However, stopping Plavix or aspirin without medical guidance may increase the risk of dangerous blood clots.
Attend regular follow-up appointments and report unusual bleeding promptly. Never stop or adjust Plavix with Aspirin without consulting your healthcare provider.
Plavix with Aspirin helps reduce the risk of harmful blood clots in appropriately selected patients with cardiovascular disease.
However, combining two antiplatelet medications increases the risk of bleeding, particularly when other blood thinners or NSAIDs are used.
Certain medications, including omeprazole and esomeprazole, may reduce the effectiveness of clopidogrel.
Genetic variations affecting CYP2C19 activity may also prevent some patients from receiving the expected antiplatelet benefits.
Your healthcare provider will consider these factors when selecting the appropriate medication, dosage, and duration of treatment.
Seek emergency medical attention if you experience severe or uncontrolled bleeding, vomiting blood, black or bloody stools, sudden weakness, difficulty speaking, or symptoms of a heart attack. Do not stop Plavix or aspirin unless your healthcare provider instructs you to do so.
The use of Plavix with aspirin during pregnancy or breastfeeding requires careful medical assessment because both medications affect blood clotting and may increase the risk of bleeding. Your healthcare provider will evaluate the potential benefits and risks before recommending this combination. During pregnancy, clopidogrel and aspirin may be prescribed in certain circumstances when preventing dangerous blood clots is considered more important than the potential risks. However, their safety depends on the medication dosage, stage of pregnancy, and underlying medical condition. Human pregnancy data for clopidogrel are limited, although available studies have not identified a clear increase in major birth defects. Aspirin requires additional consideration because its effects during pregnancy vary depending on the dosage. Low-dose aspirin is sometimes recommended for specific medical conditions, such as preventing preeclampsia in patients at increased risk. However, higher doses may increase the risk of bleeding and other complications, particularly during the later stages of pregnancy. Taking clopidogrel and aspirin together may further increase bleeding risks during pregnancy and childbirth. If you are pregnant or planning to become pregnant, inform your healthcare provider as soon as possible. Your cardiologist and obstetrician may need to coordinate your treatment to ensure the safest possible approach. Do not stop taking either medication without medical advice, particularly if you have a coronary stent or a history of serious cardiovascular events. During breastfeeding, the safety of clopidogrel and aspirin depends on the dosage, duration of treatment, and health of the nursing infant. Limited information suggests that clopidogrel passes into breast milk in small amounts, although clinical experience remains limited. Breastfed infants may require monitoring for unusual bruising, bleeding, or other unexpected symptoms. Low-dose aspirin may be compatible with breastfeeding in certain circumstances when prescribed by a healthcare provider. However, higher doses or prolonged use may increase potential risks to the nursing infant. Your healthcare provider will consider the importance of antiplatelet treatment, your baby’s health, and whether alternative medications are appropriate. Plavix with aspirin should only be used during pregnancy or breastfeeding under medical supervision. Never stop prescribed antiplatelet therapy without consulting your healthcare provider, as sudden discontinuation may increase the risk of serious blood clots, heart attacks, or other cardiovascular complications.
Yes. Plavix with Aspirin may interact with several prescription medications, over-the-counter products, and herbal supplements. Both medications reduce platelet activity, helping prevent harmful blood clots from forming. However, combining them with certain medications or supplements may increase the risk of bleeding or reduce the effectiveness of clopidogrel. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, and diclofenac, may increase the risk of stomach irritation, gastrointestinal ulcers, and bleeding when taken with Plavix and aspirin. Patients should avoid taking additional NSAIDs unless specifically recommended by their healthcare provider, as combining these medications may significantly increase bleeding risk. Anticoagulants and other blood-thinning medications, including warfarin, apixaban, and rivaroxaban, may also increase the risk of serious bleeding when used with Plavix and aspirin. Although some patients may require these combinations to manage certain cardiovascular conditions, careful medical supervision and monitoring are essential to reduce the risk of complications. Proton pump inhibitors (PPIs), which are commonly used to reduce stomach acid and treat conditions such as acid reflux and stomach ulcers, may also interact with clopidogrel. Certain PPIs, particularly omeprazole and esomeprazole, can interfere with the liver enzymes responsible for converting clopidogrel into its active form. This may reduce the medication’s ability to prevent platelet aggregation and increase the risk of blood clots. Other acid-reducing medications, such as pantoprazole, may be preferred when stomach protection is necessary because they have less effect on clopidogrel activation. Certain antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), may increase bleeding risk when combined with Plavix and aspirin. These medications can affect platelet function, potentially making bleeding more likely. Patients taking antidepressants should inform their healthcare provider before starting dual antiplatelet therapy to determine whether additional monitoring or precautions are necessary. Herbal supplements may also interact with Plavix and aspirin. For example, ginkgo biloba may increase bleeding risk because of its potential effects on platelet activity. Other supplements may interfere with cardiovascular medications or affect their effectiveness. Patients should consult their healthcare provider or pharmacist before taking herbal products, vitamins, or dietary supplements alongside Plavix and aspirin. Always inform your healthcare provider about all prescription medications, over-the-counter drugs, vitamins, and herbal supplements you take. Do not start, stop, or change any medication without medical advice, as certain combinations may increase bleeding risk or reduce the effectiveness of your antiplatelet treatment.
The length of treatment with Plavix and aspirin depends on your cardiovascular condition, medical history, previous heart procedures, and risk of bleeding. This combination is known as dual antiplatelet therapy (DAPT). It helps prevent platelets from sticking together and forming harmful blood clots that could cause heart attacks, certain strokes, or complications following coronary stent placement. For patients who have experienced acute coronary syndrome (ACS), including certain heart attacks and unstable angina, dual antiplatelet therapy is generally recommended for at least 12 months when the patient is not at high risk of bleeding. However, some patients may require a shorter treatment period, particularly if they have an increased risk of serious bleeding. Patients who have undergone coronary stent placement may also require several months of combination therapy. The duration depends on the reason for the procedure, the patient’s bleeding risk, and other cardiovascular factors. In certain circumstances, treatment may continue beyond 12 months when the benefits of preventing blood clots are considered greater than the potential bleeding risks. After completing dual antiplatelet therapy, some patients may continue taking one antiplatelet medication for long-term cardiovascular protection. Your healthcare provider will determine when combination treatment can safely be reduced, changed, or discontinued. Plavix with Aspirin is commonly prescribed for approximately 12 months following acute coronary syndrome, but the treatment duration varies. Follow your cardiologist’s instructions and never stop either medication independently.Â
No. You should not stop taking Plavix with Aspirin without consulting your healthcare provider. Both medications work by reducing platelet activity, helping prevent dangerous blood clots from forming inside blood vessels. When these medications are discontinued, platelet function gradually returns toward normal as the body produces new platelets. If treatment is stopped before it is medically appropriate, the risk of harmful blood clots may increase. This is especially concerning for patients who have recently undergone coronary stent placement. A coronary stent is a small mesh-like tube inserted into a narrowed or blocked artery to help maintain blood flow. Stopping antiplatelet therapy prematurely may allow a blood clot to form inside the stent, a complication called stent thrombosis. Stent thrombosis can suddenly block blood flow to the heart and cause a potentially life-threatening heart attack. Patients who have recently experienced acute coronary syndrome may also face an increased risk of recurrent cardiovascular events if their prescribed treatment is interrupted. Unlike certain medications that cause physical withdrawal symptoms, Plavix and aspirin do not typically cause withdrawal syndrome. The primary concern is the loss of protection against harmful blood clots. If you are scheduled for surgery, dental treatment, or another medical procedure, inform your healthcare provider that you take Plavix and aspirin. Your healthcare team will determine whether either medication needs to be temporarily interrupted and when treatment should be resumed. Never stop Plavix with Aspirin without medical advice, even if you feel well. Premature discontinuation may increase the risk of blood clots, heart attack, or stent thrombosis.Â
| Generic name: | Clopidogrel/Aspirin |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 75/75mg, 75/150mg |
| Quantities Available: | 90 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Plavix with Aspirin (clopidogrel/aspirin) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Plavix with Aspirin is commonly prescribed in combined dosages, such as clopidogrel 75 mg and aspirin 75 mg or 150 mg, taken once daily. For a 90-day supply, this means you would order 90 tablets (90 days x 1 tablet per day).
Yes, we sell clopidogrel/aspirin on our website. You can enjoy low prices when you order through us. To purchase clopidogrel/aspirin, you will need a valid prescription from your healthcare provider. We require this to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Plavix with Aspirin (clopidogrel/aspirin) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Plavix with Aspirin (Clopidogrel/Aspirin). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Plavix with Aspirin (Clopidogrel/Aspirin).
REVIEWS